Bromocriptine
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Bromoctriptine quick-release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
- Other FDA indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease
NON-FDA APPROVED USES
- Neuroleptic malignant syndrome
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Bromoctriptine quick-release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
- Other FDA indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease
NON-FDA APPROVED USES
- Neuroleptic malignant syndrome
There's more to see -- the rest of this topic is available only to subscribers.